These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11225003)

  • 1. Lung cancer.
    Worden FP; Kalemkerian GP
    Cancer Treat Res; 2001; 106():183-219. PubMed ID: 11225003
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention in head and neck cancer.
    Mellott A; Vokes E
    Cancer Treat Res; 2001; 106():221-35. PubMed ID: 11225004
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention of lung cancer--from biology to clinical reality.
    Winterhalder RC; Hirsch FR; Kotantoulas GK; Franklin WA; Bunn PA
    Ann Oncol; 2004 Feb; 15(2):185-96. PubMed ID: 14760107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of molecular abnormalities in lung cancer.
    Dziadziuszko R; Jassem E; Jassem J
    Cancer Treat Rev; 1998 Oct; 24(5):317-30. PubMed ID: 9861195
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncogenes and tumor suppressor genes involved in human lung carcinogenesis.
    Harris CC; Reddel R; Modali R; Lehman TA; Iman D; McMenamin M; Sugimura H; Weston A; Pfeifer A
    Basic Life Sci; 1990; 53():363-79. PubMed ID: 2282044
    [No Abstract]   [Full Text] [Related]  

  • 6. Oncogenes and onco-suppressor genes in lung cancer.
    Anderson ML; Spandidos DA
    Respir Med; 1993 Aug; 87(6):413-20. PubMed ID: 8210611
    [No Abstract]   [Full Text] [Related]  

  • 7. Biology of oral premalignant lesions: concepts and implications for chemoprevention.
    Papadimitrakopoulou VA; Hong WK
    Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():87-93. PubMed ID: 9061300
    [No Abstract]   [Full Text] [Related]  

  • 8. [The concept of oncogenes and anti-oncogenes].
    Jeanteur P; Pujol H; Theillet C
    Pathol Biol (Paris); 1992 Nov; 39(9):857. PubMed ID: 1538907
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Beta-carotene: a miss for epidemiology.
    Brignall M; Lamson D
    J Natl Cancer Inst; 2000 Jun; 92(12):1014; author reply 1016. PubMed ID: 10861316
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of carotenoids on the risk of lung cancer.
    Epstein KR
    Semin Oncol; 2003 Feb; 30(1):86-93. PubMed ID: 12635093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on cancer chemoprevention research and drug development.
    Kelloff GJ
    Adv Cancer Res; 2000; 78():199-334. PubMed ID: 10547671
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprevention of lung cancer: concepts and strategies.
    Cohen V; Khuri FR
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):549-65. PubMed ID: 16001960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of connexin 43 by retinoids but not by non-provitamin A carotenoids requires RARs.
    Vine AL; Bertram JS
    Nutr Cancer; 2005; 52(1):105-13. PubMed ID: 16091010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of oncogenes and anti-oncogenes in dermatology].
    Basset-Séguin N; Guillot B; Dereure O; Moles JP; Guilhou JJ
    Pathol Biol (Paris); 1992 Feb; 40(2):184-91. PubMed ID: 1608659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogenes and anti-oncogenes in lung cancer].
    Demoly P; Pujol JL; Godard P; Michel FB
    Presse Med; 1994 Feb; 23(6):291-7. PubMed ID: 8208681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of lung cancer.
    Hong WK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):135-41. PubMed ID: 10550838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial.
    Baron JA; Cole BF; Mott L; Haile R; Grau M; Church TR; Beck GJ; Greenberg ER
    J Natl Cancer Inst; 2003 May; 95(10):717-22. PubMed ID: 12759389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of lung cancer including potential clinical applications.
    Zöchbauer-Müller S; Minna JD
    Chest Surg Clin N Am; 2000 Nov; 10(4):691-708. PubMed ID: 11091920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy trial.
    Challem JJ
    J Natl Cancer Inst; 1997 Feb; 89(4):325-6. PubMed ID: 9048840
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention of lung cancer: current status and future prospects.
    van Zandwijk N; Hirsch FR
    Lung Cancer; 2003 Dec; 42 Suppl 1():S71-9. PubMed ID: 14611918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.